Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

We report on manufacturing outcomes for 41 autologous polyclonal regulatory T cell (PolyTreg) products for 7 different Phase 1 clinical trials over a 10-year period (2011-2020). Data on patient characteristics, manufacturing parameters, and manufacturing outcomes were collected from manufacturing ba...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joanna Balcerek, Brian R. Shy, Amy L. Putnam, Lisa M. Masiello, Angela Lares, Florinna Dekovic, Luis Acevedo, Michael R. Lee, Vinh Nguyen, Weihong Liu, Sreenivasan Paruthiyil, Jingying Xu, Ashley S. Leinbach, Jeffrey A. Bluestone, Qizhi Tang, Jonathan H. Esensten
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
regulatory T cell manufacturing
cGMP
ex vivo expansion
cellular therapy
regulatory T cells
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/4fbc3387d354494ba9daa3d9eab90fba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/4fbc3387d354494ba9daa3d9eab90fba

Ejemplares similares